Teva Pharmaceuticals (TEVA) and Alvotech (ALVO) announced the availability of SELARSDI injection in the U.S., a biosimilar to Stelara for the ...

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDItm for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination ...

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference ...

Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced ...

The Department of Veterans Affairs (VA) saved $67 million in 2023 through its strong adoption of biosimilars to curb the high ...

More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...

On October 14, 2024, the FDA approved a 320-mg single dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms are now commercially available in the US.

Biologics are known to be quite effective for managing moderate to severe psoriasis. Biologics are given by injection or infusion Biologics are administered either by injection or infusion.

Right first digit, pre-treatment (left) and after 60 days (2 infiltrations), 1 infiltration every 30 days (right) Connective Tissue Disease Unit, Dermatology Service, Universidade de Santo Amaro, São ...

Psoriasis symptoms can worsen in the fall and winter months for some people. For some people with psoriasis, fall and winter bring shorter days, colder weather, and worsening psoriasis symptoms ...

If you have psoriasis, you might take medication and keep close tabs on the weather, your stress level, and other triggers. Should you also watch what's on your plate? A healthy diet -- lots of ...

White matter and other changes around the toenails and fingernails can occur with psoriasis or nail fungus. However, fungal infections are contagious, and psoriasis is not. The causes and ...